Dr Agarwals Health IPO Review | Dr Agarwals Health IPO Subscription | Dr Agarwals Health IPO Anchor Investors Allocation |

Dr Agarwals Health IPO Description – Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care. As of the Financial Year 2024, the company held approximately 25% of India’s total market share in the eye care service chain.
Dr. Agarwal’s Eye Hospital has a rich operational history, focusing on meeting the diverse needs of its patients throughout their eye treatment journey. As of 31 March 2024, the network comprised 180 facilities staffed by 667 doctors. During the financial year 2024, the organization served 2.13 million patients and performed 2,20,523 surgeries.
As of 30 September 2024, the company operated 193 facilities across 117 metro and non-metro cities spanning 14 states, four union territories in India, and 16 facilities in nine African countries.

Promoters of Dr. Agarwal’s Health Care – Dr. Amar Agarwal, Dr. Athiya Agarwal, Dr. Adil Agarwal, Dr. Anosh Agarwal, Dr. Ashvin Agarwal, Dr. Ashar Agarwal, Dr. Amar Agarwal Family Trust, Dr. Adil Agarwal Family Trust, Dr. Anosh Agarwal Family Trust, Dr. Ashvin Agarwal Family Trust, Dr. Ashar Agarwal Family Trust, Dr. Agarwal’s Eye Institute, and Dr. Agarwal’s Eye Institute Private Limited
Table of Contents
Dr. Agarwals Health IPO Details
Dr Agarwals Health IPO Dates | 29 – 31 January 2025 |
Dr Agarwals Health Care IPO Price | INR 382 – 402 per share |
Fresh issue | INR 300 crore |
Offer For Sale | 6,78,42,284 Shares INR 2,591.57 – 2,727.26 crore |
Total IPO size | INR 2,891.57 – 3,027.26 crore |
Minimum bid (lot size) | 35 Shares (INR 14,070) |
Shareholders Reservation | 11,29,574 Shares |
Face Value | INR 1 per share |
Retail Allocation | 35% |
Listing On | NSE, BSE |
Dr Agarwals Health Financial Performance
FY 2022 | FY 2023 | FY 2024 | H1 FY 2025 | |
Revenue | 696.08 | 1,017.98 | 1,332.15 | 820.06 |
Expenses | 657.02 | 947.90 | 1,235.88 | 777.59 |
Net income | 37.69 | 94.10 | 83.06 | 28.56 |
Margin (%) | 5.41 | 9.24 | 6.23 | 3.48 |
Dr. Agarwals Health Offer News
- Dr. Agarwals Health RHP
- Dr. Agarwals Health DRHP
- ASBA IPO Forms
- Live IPO Subscription Status
- IPO Allotment Status
Dr Agarwals Health Valuations & Margins
FY 2023 | FY 2024 (Pre Issue) | FY 2025 (Post-Issue)* | |
EPS | 4.00 | 3.13 | 1.81 |
PE Ratio | – | 122.04 – 128.43 | 211.05 – 222.10 |
FY 2022 | FY 2023 | FY 2024 | |
RONW (%) | 17.75 | 14.99 | 6.21 |
NAV | 10.32 | 26.73 | 50.53 |
ROCE (%) | 15.02 | 15.18 | 14.61 |
EBITDA (%) | 27.99 | 27.52 | 29.54 |
Debt/Equity | 2.21 | 1.08 | 0.61 |
Dr Agarwals Health IPO GMP Today (Daily Trend)
Date | Day-wise IPO GMP | Kostak | Subject to Sauda |
3 February 2025 | 3 | – | – |
1 February 2025 | 3 | – | – |
31 January 2025 | 3 | – | – |
30 January 2025 | 5 | – | – |
29 January 2025 | 12 | – | 500 |
28 January 2025 | 18 | – | 900 |
27 January 2025 | 33 | – | 1,300 |
25 January 2025 | 45 | – | 3,000 |
Dr Agarwals Health IPO Objectives
The company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
- Repayment/prepayment, in part or full, of certain of the borrowings – INR 195 crore
- General corporate purposes and unidentified inorganic acquisition
Dr. Agarwal’s Health – Comparison With Listed Peers
Company | PE ratio | EPS | RONW (%) | NAV | Revenue (Cr.) |
Dr. Agarwal’s Health Care | 222.10 | 3.13 | 6.21 | 50.53 | 1,332.15 |
Apollo Hospitals Enterprise | 113.47 | 62.50 | 12.97 | 481.93 | 19,059.20 |
Max Healthcare | 98.56 | 10.84 | 12.58 | 86.54 | 6,849.00 |
Fortis Healthcare | 76.33 | 7.93 | 7.82 | 101.48 | 6,892.92 |
Global Health | 62.32 | 17.80 | 16.46 | 108.17 | 3,275.11 |
Dr Agarwals Health IPO Allotment Status
Dr Agarwals Health IPO allotment status is now available on the KFin Tech website. Click on this link to get allotment status.
Dr Agarwals Health IPO Dates & Listing Performance
IPO Opening Date | 29 January 2025 |
IPO Closing Date | 31 January 2025 |
Finalization of Basis of Allotment | 1 February 2025 |
Initiation of refunds | 3 February 2025 |
Transfer of shares to demat accounts | 3 February 2025 |
Dr Agarwal’s Health IPO Listing Date | 4 February 2025 |
Opening Price on NSE | INR 402 per share (Flat Listing) |
Closing Price on NSE | INR 400 per share (down 0.50%) |
Dr Agarwals Health IPO Reviews – Subscribe or Avoid?
Adroit Financial – Subscribe
Anand Rathi – Subscribe for long term
Antique Stock Broking –
Ajcon Global –
Arihant Capital –
Axis Capital – Not rated
Ashika Research – Not rated
BP Wealth – Avoid
Capital Market – Avoid
Canara Bank Securities – Neutral
Choice Broking –
Dalal & Broacha –
Eureka Stock – Neutral
Elite Wealth – Apply
GCL Broking –
Geojit – Subscribe for long term
GEPL Capital –
Hem Securities – Subscribe for long term
Hensex Securities –
HDFC Securities –
ICICIdirect –
IDBI Capital –
Investmentz –
Indsec Securities –
Jainam Broking – Avoid
KR Choksey –
LKP Research –
Marwadi Financial –
Motilal Oswal –
Mehta Equities – Subscribe for long term
Nirmal Bang –
Reliance Securities –
Sushil Finance –
Samco Securities – Avoid
SBI Securities – Subscribe for long term
SMC Global – 1.5/5
SMIFS –
Systematix Research –
Swastika Investmart –
Ventura Securities – Not rated
Dr Agarwals Health Offer Lead Manager
KOTAK MAHINDRA CAPITAL COMPANY LIMITED
27 BKC, 1st Floor, Plot no. C-27,
‘G’ Block, Bandra Kurla Complex,
Bandra (East), Mumbai 400 051
Phone: +91 22 4336 0000
Email: [email protected]
Website: www.investmentbank.kotak.com
Dr. Agarwal’s Health Offer Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com
Dr Agarwals Health Contact Details
DR. AGARWAL’S HEALTH CARE LIMITED
3rd Floor, Buhari Towers, No.4, Moores Road,
Off Greams Road, Chennai 600 006, Tamil Nadu
Phone: +91 44 4378 7777
Email: [email protected]
Website: www.dragarwals.co.in
Dr Agarwal’s Health Care IPO FAQs
How many shares in Dr Agarwals Health IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.
How to apply for Dr Agarwals Health Public Offer?
The best way to apply for Dr. Agarwal’s Health public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is Dr Agarwals Health IPO GMP today?
Dr Agarwals Health IPO GMP today is INR 3 per share.
What is Dr Agarwal’s Health kostak rate today?
Dr. Agarwal’s Health kostak rate today is INR NA per application.
What is Dr Agarwal’s Health Subject to Sauda rate today?
Dr. Agarwal’s Health Subject to Sauda rate today is INR NA per application.